Amyloidosis Light-chain

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-03-06
Clinical Trial Update: Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE) [Phase 1, Phase 2]
The ALTITUDE trial evaluating venetoclax, daratumumab, and dexamethasone for systemic light-chain (AL) amyloidosis with t(11;14) has been wi…